Comments
Pharma major Dr Reddy’s Laboratories Ltd has launched chlordiazepoxide hydrochloride and clidinium bromide capsules, a therapeutic equivalent generic version of Librax (chlordiazepoxide hydrochloride and clidinium bromide) approved by the US Food and Drug Administration (USFDA).
The Librax® brand and generic market had US sales of approximately $105.9 million for the most recent twelve months ending in July 2021, according to IQVIA Health.
Hyderabad-based Dr Reddy’s chlordiazepoxide hydrochloride and clidinium bromide capsules, USP are available in one strength of 5mg/2.5mg capsules in bottle count sizes of 100, the company said in a release.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.